
### [MONDO:0001018](http://purl.obolibrary.org/obo/MONDO_0001018)
**Label:** lymphoblastic leukemia

**Subclasses:** [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0004963](http://purl.obolibrary.org/obo/MONDO_0004963) (T-cell acute lymphoblastic leukemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), 

**Corr. equiv. classes:** [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [OMIM:186770](http://purl.obolibrary.org/obo/OMIM_186770), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [OMIM:613065](http://purl.obolibrary.org/obo/OMIM_613065), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [OMIM:247640](http://purl.obolibrary.org/obo/OMIM_247640), [OMIM:613067](http://purl.obolibrary.org/obo/OMIM_613067), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:615545](http://purl.obolibrary.org/obo/OMIM_615545), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), 

**Class expressions from DL-Learner:**

- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 41.27%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 41.27%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 41.27%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 40.62%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001894](http://purl.obolibrary.org/obo/HP_0001894) (Thrombocytosis))) 34.80%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 33.76%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 33.35%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 33.18%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 29.65%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 29.60%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 28.47%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 28.17%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 27.32%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 26.97%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) 26.97%



### [MONDO:0001018](http://purl.obolibrary.org/obo/MONDO_0001018)
**Label:** lymphoblastic leukemia

**Subclasses:** [MONDO:0004963](http://purl.obolibrary.org/obo/MONDO_0004963) (T-cell acute lymphoblastic leukemia), [MONDO:0007243](http://purl.obolibrary.org/obo/MONDO_0007243) (Burkitts lymphoma), [MONDO:0004948](http://purl.obolibrary.org/obo/MONDO_0004948) (chronic lymphocytic leukemia), [MONDO:0020511](http://purl.obolibrary.org/obo/MONDO_0020511) (precursor b-cell acute lymphoblastic leukemia), [MONDO:0004967](http://purl.obolibrary.org/obo/MONDO_0004967) (acute lymphoblastic leukemia (disease)), 

**Corr. equiv. classes:** [Orphanet:99860](http://www.orpha.net/ORDO/Orphanet_99860), [OMIM:186770](http://purl.obolibrary.org/obo/OMIM_186770), [OMIM:113970](http://purl.obolibrary.org/obo/OMIM_113970), [OMIM:613065](http://purl.obolibrary.org/obo/OMIM_613065), [OMIM:151400](http://purl.obolibrary.org/obo/OMIM_151400), [OMIM:247640](http://purl.obolibrary.org/obo/OMIM_247640), [OMIM:613067](http://purl.obolibrary.org/obo/OMIM_613067), [Orphanet:67038](http://www.orpha.net/ORDO/Orphanet_67038), [OMIM:615545](http://purl.obolibrary.org/obo/OMIM_615545), [OMIM:612558](http://purl.obolibrary.org/obo/OMIM_612558), [OMIM:612557](http://purl.obolibrary.org/obo/OMIM_612557), [OMIM:609630](http://purl.obolibrary.org/obo/OMIM_609630), [OMIM:612559](http://purl.obolibrary.org/obo/OMIM_612559), [OMIM:109543](http://purl.obolibrary.org/obo/OMIM_109543), [Orphanet:543](http://www.orpha.net/ORDO/Orphanet_543), [Orphanet:513](http://www.orpha.net/ORDO/Orphanet_513), 

**Class expressions from DL-Learner:**

- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system))) 41.27%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000951](http://purl.obolibrary.org/obo/HP_0000951) (Abnormality of the skin))) 41.27%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system))) 41.27%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system))) 40.62%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) and (not ([HP:0001894](http://purl.obolibrary.org/obo/HP_0001894) (Thrombocytosis))) 34.80%
- [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 33.76%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0001909](http://purl.obolibrary.org/obo/HP_0001909) (Leukemia) 33.35%
- [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 33.18%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 29.65%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0004377](http://purl.obolibrary.org/obo/HP_0004377) (Hematological neoplasm) 29.60%
- [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 28.47%
- [HP:0002664](http://purl.obolibrary.org/obo/HP_0002664) (Neoplasm) 28.17%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 27.32%
- [HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system) 26.97%
- [HP:0001881](http://purl.obolibrary.org/obo/HP_0001881) (Abnormality of leukocytes) 26.97%


